Navigation Links
Multi Merci Trial Results Published in Peer Reviewed Journal
Date:3/6/2008

MOUNTAIN VIEW, Calif., March 6 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the results of its Multi MERCI trial will be published in the April 2008 edition of the medical journal, Stroke. The Multi MERCI trial was the second trial studying safety and efficacy of the Merci Retrieval System(TM), a "corkscrew-type" device that is delivered into the brain and is designed to restore blood flow by engaging, capturing and removing blood clots that cause ischemic stroke. The full, peer reviewed trial results are available now to online subscribers. Stroke is published by the American Heart Association.

In the Multi MERCI trial, patients treated with the newer Merci(R) L5 Retriever had their cerebral blood flow successfully restored 57.3% of the time with the Merci Retrieval System alone. With the addition of adjunctive therapy, physicians successfully restored cerebral blood flow 69.5% of the time. For patients to be successfully revascularized, not only the target vessel, but all treatable downstream vessels needed to achieve TIMI 2 or 3 flow.

In addition, a total of 36% of all patients treated achieved a "good" outcome at 90 days post procedure, a higher rate than reported in any other device trial in large vessel acute ischemic stroke patients. Ninety-day clinical outcomes in stroke trials are generally measured using the modified Rankin Score, a measure of functional independence, with a score of 2 or less considered a good outcome. These outcome data are superior to those reported in recent studies of other devices in which successful revascularization was not as stringently defined.

Multi MERCI was a multi-center, prospective trial including 164 patients treated at 15 hospitals in the United States and Canada. All patients had moderate-to-severe, large vessel ischemic strokes. The trial included patients who were ineligible for or had failed treatm
'/>"/>

SOURCE Concentric Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
2. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
3. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
4. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
5. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
6. SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
7. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
8. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
9. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... MOUNT PROSPECT, Ill. , July 31, 2015 ... of Pharmacy ® (NABP ® ) issued ... charged with ensuring that action is taken against ... the Internet Drug Outlet Identification Program ... 2015 , thousands of websites ...
(Date:7/31/2015)... -- According to a new market research report ... Ethylene Oxide, Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables ... Forecast to 2020", published by MarketsandMarkets, The Sterilization Equipment Market ... at a CAGR of 7.6%.from 2015 to 2020. ... ables and 37 F ...
(Date:7/31/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company ... and physician groups, today reported financial results for the ... "In the second quarter of 2015, Semler reported continued ... quarter over quarter revenue growth of 8%, and quarter ... units of 18%," said Doug Murphy-Chutorian, M.D., chief executive ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... Corporation (Nasdaq: DRRX ) today reported that King ... Inc. (Nasdaq: PTIE ) have announced that King ... the U.S. Food and Drug Administration (FDA) in response to ... 2008.  This is a Class 2 resubmission with a six ...
... During ICMS (International Cellular Medicine Society www.cellmedicinesociety.org ) ... Conference held on November 12, 2010 in Las Vegas, ... of diabetes gangrene recovered from foot ulcer through stem ... ) Patient, Sun Rae Cho (age 72 ...
Cached Medicine Technology:REMOXY® New Drug Application Resubmitted 2REMOXY® New Drug Application Resubmitted 3New Hope for Saving Diabetic Foot from Amputation 2
(Date:8/1/2015)... ... 01, 2015 , ... Calvary Hospital today announced that it is embarking on ... goal is to bring this Torah – dating from 1880 – back to kosher ... services. , Scroll No. 515, from the town of Taus-Domazlice, is on permanent ...
(Date:8/1/2015)... ... 2015 , ... On Tuesday, July 28th, Symantec released a security industry ... behind the attack on Anthem Inc. which resulted in one of the largest data ... and spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO of ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – ... trek of the Appalachian Trail by stepping off Springer Mountain and heading north. ... On July 26th Phil reached Connecticut and was greeted by friends and family. He ...
(Date:7/31/2015)... (PRWEB) , ... August 01, 2015 , ... The Honor ... Global Advisory Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in San ... to participate in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by Becker’s Healthcare ... health analytics , Jvion continues to disrupt the predictive analytic and big data ... patient and population level illness to drive prevention and better health outcomes. Most ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... Oct. 31Like normal tissue, tumors thrive on nutrients carried ... of new blood vessels is a hallmark of cancer, ... can keep tumors from growing, too. To better understand ... would like to make detailed maps of the complete ...
... to popular belief, most college students don,t gain anywhere near ... nationwide study. Rather than adding "the freshman 15," as ... 2.5 and 3.5 pounds during the first year of college. ... gain, the study revealed. The typical freshman only gains about ...
... An international collaboration of scientists, including researchers at ... Skin Diseases (NIAMS), a part of the National ... that causes a rare childhood disease characterized predominantly ... that the disorder, named chronic atypical neutrophilic dermatosis ...
... hypertension (PAH) is a rare form of pulmonary hypertension (PH) that ... people out of one million people worldwide per year - most ... 40. While the numbers may not seem significant, the disease ... the causes of PAH remain unknown. As the ...
... , MONDAY, Oct. 31 (HealthDay News) -- Construction workers ... injuries and an increased risk of work-related illness and death, ... national sources and found that a construction worker has a ... 45-year career, and a 1-in-200 risk of being fatally injured ...
... by the Institute for Health Metrics and Evaluation (IHME) ... improved methods for analyzing verbal autopsies a method ... a complete vital registration system are fast, effective, ... to understand disease trends., While many high-income countries such ...
Cached Medicine News:Health News:The 'freshman 15' is just a myth, nationwide study reveals 2Health News:The 'freshman 15' is just a myth, nationwide study reveals 3Health News:NIH scientists discover link among spectrum of childhood diseases 2Health News:LA BioMed's Dr. Ronald Oudiz impacting lives of those with pulmonary hypertension 2Health News:'Hard Hats' Still Have High Rates of Injury, Illness: Report 2Health News:IHME develops fast, affordable ways for countries to better identify causes of death in populations 2Health News:IHME develops fast, affordable ways for countries to better identify causes of death in populations 3Health News:IHME develops fast, affordable ways for countries to better identify causes of death in populations 4
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
MagPrep® Streptavidin Beads are encapsulated super-paramagnetic polystyrol particles coated with streptavidin. The beads have a diameter of 1 m and are provided as a stabilized aqueous suspensio...
For general purposes...
... is a method for isolating antibodies, ... cells using affinity binding, while retaining ... on the particles to separate biotinylated ... the MagnaBind™ Beads from the suspension, ...
Medicine Products: